|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/10 | |
| A61K 31/498 | |||
| A61K 9/16 |
| (11) | Patento numeris | 1879553 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06752463.7 |
| Europos patento paraiškos padavimo data | 2006-05-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-01-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/018019 |
| Data | 2006-05-09 |
| (87) | Numeris | WO 2006/122165 |
| Data | 2006-11-16 |
| (30) | Numeris | Data | Šalis |
| 679771 P | 2005-05-10 | US |
| (72) |
HUGHES, Patric, M., US
BURKE, James, A., US
CHANG-LIN, Joan-En, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | OCULAR THERAPY USING ALPHA-2 ADRENERGIC RECEPTOR AGONISTS HAVING ENHANCED ANTERIOR CLEARANCE RATES |
| OCULAR THERAPY USING ALPHA-2 ADRENERGIC RECEPTOR AGONISTS HAVING ENHANCED ANTERIOR CLEARANCE RATES |